Zydus Lifesciences Ltd 2023 SR
The report details Zydus Lifesciences Limited's ESG performance for the fiscal year 2022-23, highlighting a 20% reduction in GHG intensity and a 150% increase in renewable energy utilization. The company achieved a 9% reduction in water intensity and reused over 40% of its water consumption. Key initiatives include the 'wealth from waste' strategy, achieving 47% waste recycling, and significant investments in R&D for innovative drugs and biosimilars. Zydus also emphasizes its commitment to access to healthcare through its Medical College and Hospital in Dahod and the launch of affordable biosimilars.
Company: Zydus Lifesciences Ltd
Sector: Health Care
Country: India
Year: 2023
Type: SR
Pages: 53
Zydus Lifesciences Ltd
ESG Report
The report details Zydus Lifesciences Limited's ESG performance for the fiscal year 2022-23, highlighting a 20% reduction in GHG intensity and a 150% increase in renewable energy utilization. The company achieved a 9% reduction in water intensity and reused over 40% of its water consumption. Key initiatives include the 'wealth from waste' strategy, achieving 47% waste recycling, and significant investments in R&D for innovative drugs and biosimilars. Zydus also emphasizes its commitment to access to healthcare through its Medical College and Hospital in Dahod and the launch of affordable biosimilars.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities